Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients-Reference-Cited by-同舟云学术

Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients

Published:2018-11-29 Issue:1 Volume:8 Page:
ISSN:2158-3188
Container-title:Translational Psychiatry
language:en
Short-container-title:Transl Psychiatry

Author:

An Huimei,Du Xiangdong,Huang Xingbing,Qi Lingyan,Jia Qiufang,Yin Guangzhong,Xiao Chunling,Huang Xu-Feng^ORCID,Ning Yuping,Cassidy Ryan M,Wang Li,Soares Jair C.,Zhang Xiang Yang

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Beijing Municipal Excellent Talents Foundation

Beijing Science and Technology Foundation

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Cellular and Molecular Neuroscience,Psychiatry and Mental health

Link

http://www.nature.com/articles/s41398-018-0303-7.pdf

Reference59 articles.

1. Allison, D. B. et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am. J. Prev. Med. 36, 341–350 (2009).

2. Li, Q. et al. The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia. Psychiatry Res. 251, 131–136 (2017).

3. Manu, P. et al. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatr. Scand. 132, 97–108 (2015).

4. Weiden, P. J., Mackell, J. A. & McDonnell, D. D. Obesity as a risk factor for antipsychotic noncompliance. Schizophr. Res. 66, 51–57 (2004).

5. Castillo-Sanchez, M., Fabregas-Escurriola, M., Berge-Baquero, D., Fernandez-SanMartin, M. & Goday-Arno, A. Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population? Clin. Exp. Hypertens. 39, 441–447 (2017).

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective effects of alpha-pinene against behavioral deficits in ketamine-induced mice model of schizophrenia: Focusing on oxidative stress status;IBRO Neuroscience Reports;2024-06

2. Variations to plasma H2O2 levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: Correlations with psychopathology;Schizophrenia;2024-04-11

3. Total antioxidant capacity, obesity and clinical correlates in first-episode and drug-naïve patients with schizophrenia;Schizophrenia Research;2024-02

4. Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study;Frontiers in Pharmacology;2023-11-09

5. Antioxidative effect of Aloe vera against malathion induced neurotoxic response in Wistar rats;Arabian Journal of Chemistry;2023-10